Adrenocortical carcinoma with skeletal metastases in a postmenopausal woman.

Indian J Med Paediatr Oncol

Department of Radiotherapy, Medical College Hospital, 88, College Street, Kolkata - 700 073, India.

Published: January 2009

Adrenocortical cancer is a very rare tumor with a poor prognosis. About half of them are hormone-secreting tumors. In most cases, hormonal investigations reveal an excess secretion of steroids, mostly cortisol and androgens. A 54-year-old lady presented with history of pain in left shoulder and leg for 6 months and features of virilization. CT-guided fine-needle aspiration cytology of an abdominal mass revealed the presence of a carcinoma of the left adrenal cortex. A whole-body radionuclide bone scan revealed increased uptake in the left clavicle and left femur. The patient has received palliative radiotherapy for the skeletal lesions and 3 cycles of palliative chemotherapy at present.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902211PMC
http://dx.doi.org/10.4103/0971-5851.56332DOI Listing

Publication Analysis

Top Keywords

adrenocortical carcinoma
4
carcinoma skeletal
4
skeletal metastases
4
metastases postmenopausal
4
postmenopausal woman
4
woman adrenocortical
4
adrenocortical cancer
4
cancer rare
4
rare tumor
4
tumor poor
4

Similar Publications

Objectives: Urinary steroid profiling after hydrolysis of conjugates is an emerging tool to differentiate aggressive adrenocortical carcinomas (ACC) from benign adrenocortical adenomas (ACA). However, the shortcomings of deconjugation are the lack of standardized and fully validated hydrolysis protocols and the loss of information about the originally conjugated form of the steroids. This study aimed to evaluate the quality of the deconjugation process and investigate novel diagnostic biomarkers in urine without enzymatic hydrolysis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!